EA2131
|
ECOG-ACRIN
|
A Phase I and Randomized Phase II Study of Nab-Paclitaxel/Gemcitabine with or without AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
EA2142
|
ECOG-ACRIN
|
Randomized Phase II Study of Platinum and Etoposide versus Temozolomide and Capecitabine in Patients with Advanced G3 Non-Small Cell Gastroenteropancreatic Neuroendocrine Tumors including Poorly Differentiated Neuroendocrine Carcinomas and Well-Differentiated Neuroendocrine Neoplasms
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
EA2161
|
ECOG-ACRIN
|
A Phase II Study of MLN0128 (TAK-228) in Rapalog-Resistant Advanced Pancreatic Neuroendocrine Tumors (PNET)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
EA2165
|
ECOG-ACRIN
|
A Randomized Phase II Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
EA2174
|
ECOG-ACRIN
|
A Phase II/III Study of Peri-operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
EA2176
|
ECOG-ACRIN
|
A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Naïve Metastatic Anal Cancer Patients
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
EA2182
|
ECOG-ACRIN
|
A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
EA2183
|
ECOG-ACRIN
|
A Phase III Study of Consolidative Radiotherapy in Patients with Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
EA2185
|
ECOG-ACRIN
|
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
EA2186
|
ECOG-ACRIN
|
A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Naïve Metastatic Pancreatic Cancer (GIANT)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|